Some massive winners in the world of biotech companies continue to emerge today. 4D Molecular Therapeutics (NASDAQ:FDMT) is the latest company to generate massive attention from investors, with FDMT stock rocketing over 80% higher in early afternoon trading.This move comes as the company announced positive interim data from a key Phase 2 clinical trial of its eye disease therapy, 4D-150. These clinical trials were carried out in “wet age-related macular degeneration (wet AMD) patients with severe disease ac ...